Hims Hers Health Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.6% | +1.6% | +7.2% | +25.3% | +17.5% | +26.0% | +110.6% | +18.9% | -3.5% | +5.2% | +60.1% | |
| – | +5.9% | -1.3% | +11.2% | +12.2% | +21.3% | +12.9% | +203.3% | -37.6% | -9.2% | +36.2% | +32.5% | |
| – | +66.7% | +8.9% | +22.9% | +28.0% | +33.3% | +24.1% | +310.8% | -69.3% | -33.9% | -2.8% | +174.4% | |
| – | +4.0% | -7.9% | +11.6% | +11.8% | +18.2% | +7.5% | +254.7% | -45.0% | -8.3% | +30.0% | +12.0% | |
| – | +59.6% | -5.1% | -13.3% | -17.6% | +32.9% | +14.2% | -3.0% | +513.7% | -22.2% | +365.4% | +150.8% | |
| – | +2.1% | +32.8% | +36.1% | +21.0% | +31.2% | +18.1% | +86.3% | -25.3% | +9.2% | -26.8% | +3.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +1.7% | +0.0% | +4.5% | +0.0% | +120.2% | +7.4% | +23.2% | +221.4% | |
| – | -3.7% | -3.8% | -4.1% | +161.6% | -3.1% | +0.0% | -6.4% | +379.5% | +0.6% | +33.1% | +62.0% | |
| – | +13.9% | +6.7% | +14.4% | +36.8% | +42.3% | +48.4% | +284.0% | +25.7% | -2.3% | +12.8% | +81.5% | |
| – | +7.2% | +5.5% | +16.4% | +40.5% | +45.0% | +26.7% | -2.9% | +65.6% | -10.3% | +53.0% | +139.7% | |
| – | -33.6% | +20.5% | +5.8% | +9.7% | +5.4% | +97.8% | -16.1% | +9.2% | +41.5% | +15.2% | +107.0% | |
| – | +2.5% | +2.0% | +30.0% | +32.1% | +20.9% | +19.5% | -3.6% | +88.9% | -27.8% | +114.2% | +63.4% | |
| – | – | – | – | – | – | – | – | +0.2% | +0.2% | +0.2% | +40.2% | |
| – | +4.7% | +0.1% | +5.1% | +21.6% | +8.3% | +15.2% | +2.4% | +3.2% | -6.9% | -17.5% | -27.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | +9.4% | +2.4% | +0.1% | +2.4% | +2.4% | +4.1% | -3.2% | -0.2% | -8.0% | +1.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.